Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2024 call → NOWe need to determine if management's forward account is substantially about narrating what its counterparties are themselves doing and scaling. The question asks: does management explain where the company's business is going by narrating what its counterparties are themselves doing and scaling? That is, does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? We need to look at the transcript. Management talks about its own brands, launches, marketing, etc. But also mentions partners like Inter Parfums for fragrance, and licensees. However, the question is about counterparties' own trajectories driving the company's volume. For example, if they say "our licensee is expanding into new categories" and that drives our revenue. Or "our distributor is opening new stores" and that drives our sales. In the transcript, management discusses its own initiatives: launching Donna Karan, Nautica, Halston, Champion, etc. They talk about their own marketing campaigns, their own investments. They also mention that they are working with new distribution partners to grow into new categories. But do they narrate the counterparties' own scaling? For instance, they mention that they have a fragrance partner Inter Parfums, but they don't describe Inter Parfums' own expansion plans. They mention that they are selling to the brand's global distribution network for Nautica, but that's about their own distribution. They also talk about their retail segment, but that's their own stores. They mention that they have licensees for Karl Lagerfeld, and that they are expanding into new markets and categories. But again, that's their own doing. The key is: does management describe what specific counterparties are themselves building or scaling? For example, they might say "our licensee is opening 100 new stores" or "our distributor is entering new countries" and that drives our sales. I don't see that in the transcript. They talk about their own plans, their own marketing, their own product launches.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.